DOI: 10.1097/01.COT.0000333619.42036.2f

,  

Issn Print: 0276-2234

Publication Date: 2008/07/25


Print

Updates on DLBCL from the International Conference on Malignant Lymphoma

ROBERT H. CARLSON

    loading  Checking for direct PDF access through Ovid

Excerpt

LUGANO, Switzerland—The session on diffuse large B-cell lymphoma (DLBCL) at the 10th International Conference on Malignant Lymphoma included presentations on the value of PET scans in mid-treatment, the effects of intensifying the dose of rituximab in a dose-dense R-CHOP-14 regimen, and evidence that three major subtypes of DLBCL differ by genetic pathways.

Related Topics

    loading  Loading Related Articles